Dose-Proportionality and Food Effect Study of TNX-102 SL

Clinical trial NCT04164719 · COMPLETED

Trial details

NCT number: NCT04164719
Sponsor: Tonix Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2019-10-14
Primary completion: 2019-12-24
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.